Spero Therapeutics, Inc. (SPRO) Net income 2016–2025
Spero Therapeutics, Inc. (SPRO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$8.6MFY2025 · since FY2016: -$25.5M → $8.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.6M | +112.5% |
| FY2024 | -$68.6M | -400.6% |
| FY2023 | $22.8M | +149.1% |
| FY2022 | -$46.4M | +48.3% |
| FY2021 | -$89.8M | -14.7% |
| FY2020 | -$78.3M | -28.6% |
| FY2019 | -$60.9M | -46.0% |
| FY2018 | -$41.7M | -7.6% |
| FY2017 | -$38.7M | -52.0% |
| FY2016 | -$25.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice